close :

:

Forgotten your password?
 

New Drug Approvals Archive

New Drug Approvals: November 2005

November 2
Exjade (deferasirox) Dispersible Tablets

Date of Approval: November 2, 2005

Company: Novartis

Treatment for Chronic Iron Overload Due to Blood Transfusions

Exjade is a once-daily oral iron chelator approved for the treatment of chronic iron overload due to blood transfusions in adults and children age two and older.

Exjade Novartis - Treatment for Chronic Iron Overload Due to Blood Transfusions
 

New Drug Approvals Archive

2008: Jan | Feb | Mar | Apr | May
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Oct | Dec

More News Resources


Join Drugs.com
Click here to see what benefits you can get by joining our FREE membership programme.
Drugs.com is the most popular, comprehensive, and up-to-date source of drug information online. Providing advice on more than 24,000 prescription drugs and over-the-counter medicines for consumers and professionals .
Advertisement
In The Pipeline